DENVER--(BUSINESS WIRE)--Sept. 20, 2006--Myogen, Inc. (Nasdaq: MYOG), a biopharmaceutical company focused on the discovery, development and commercialization of small molecule therapeutics for the treatment of cardiovascular disorders, today announced that J. William Freytag, President and CEO, will present a corporate overview at the UBS Global Life Sciences Conference to be held Sept. 25-28, 2006, at the Grand Hyatt Hotel in New York City.
